)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Initiator Pharma (INIT) investor relations material
Initiator Pharma Investing in Life Science 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investing in Life Science 2025 summary25 Sep, 2025
Company mission and lead candidate
Focuses on developing transformative treatments for sexual dysfunctions and pain, targeting both men and women.
Lead candidate, putafencin, acts on the central nervous system, offering efficacy and safety in both sexual dysfunction and pain.
Distinguishes itself from competitors by modulating dopamine centrally, reducing side effects compared to traditional treatments.
Clinical progress and pipeline
Phase 2b study in men with moderate to severe erectile dysfunction showed increased sexual responses with no significant side effects.
Preclinical and clinical data support expansion into women's health, especially for vulvodynia, a high unmet need.
Preparing for a Phase II trial in vulvodynia, aiming to start dosing by end of the year, with a four-way crossover design.
Additional pipeline includes IP2018 for psychogenic erectile dysfunction and a preclinical pain candidate.
Market opportunity and strategy
Vulvodynia affects millions in Europe and the US, with no approved treatments and a potential $1–2 billion peak sales market.
Focused on Europe and the US for market entry, seeking partners with launch infrastructure.
Raising awareness of vulvodynia is a priority, leveraging growing attention in women's health.
Vulvodynia market entry strategy and partners?
IP 2018's potential beyond psychogenic ED?
What is Putafencin's competitive edge in pain/ED?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Initiator Pharma earnings date
Q3 202521 Nov, 2025
Next Initiator Pharma earnings date
Q3 202521 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Initiator Pharma A/S is a Danish clinical-stage biopharmaceutical company focusing on developing treatments for unmet medical needs related to the central and peripheral nervous systems. The company’s portfolio primarily targets disorders such as erectile dysfunction (ED) and neuropathic pain. Its clinical programs include drug candidates for both psychogenic and organic ED as well as a rare disease program for Trigeminal Neuralgia, a chronic pain condition. Initiator Pharma leverages its expertise in monoamine reuptake inhibitors, which increase key neurotransmitters like dopamine to treat various neurological conditions. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage